Cutaneous leishmaniasis induced by TNF-α blockers: a diagnostic challenge

Int J Dermatol. 2021 Mar;60(3):e101-e103. doi: 10.1111/ijd.15222. Epub 2020 Sep 29.

Authors

Teresa Ródenas-Herranz¹, Laura Linares-González¹, Isabel Carpena-Martínez², Miguel Pérez-Ramos³, Ricardo Ruiz-Villaverde¹

Affiliations

¹ Dermatology Department, Hospital Universitario San Cecilio, Granada, Spain.
² Internal Medicine Department, Hospital Universitario Morales Meseguer, Murcia, Spain.
³ Pathology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.

PMID: 32989744
DOI: 10.1111/ijd.15222

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents*
Humans
Immunologic Factors
Leishmaniasis, Cutaneous* / diagnosis
Leishmaniasis, Cutaneous* / drug therapy
Tumor Necrosis Factor-alpha

Substances

Antineoplastic Agents
Immunologic Factors
Tumor Necrosis Factor-alpha